Walsh CS - Search Results

1

A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.

Mortlock S, Corona RI, Kho PF, Pharoah P, Seo JH, Freedman ML, Gayther SA, Siedhoff MT, Rogers PAW, Leuchter R, Walsh CS, Cass I, Karlan BY, Rimel BJ; Ovarian Cancer Association Consortium, International Endometriosis Genetics Consortium; Montgomery GW, Lawrenson K, Kar SP. Mortlock S, et al. Among authors: walsh cs. Cell Rep Med. 2022 Mar 15;3(3):100542. doi: 10.1016/j.xcrm.2022.100542. eCollection 2022 Mar 15. Cell Rep Med. 2022. PMID: 35492879 Free PMC article.

2

Coexisting ovarian malignancy in young women with endometrial cancer.

Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Walsh C, et al. Obstet Gynecol. 2005 Oct;106(4):693-9. doi: 10.1097/01.AOG.0000172423.64995.6f. Obstet Gynecol. 2005. PMID: 16199623

3

The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.

Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ. Lerner DL, et al. Among authors: walsh cs. Gynecol Oncol. 2007 Jan;104(1):91-4. doi: 10.1016/j.ygyno.2006.07.020. Epub 2006 Aug 24. Gynecol Oncol. 2007. PMID: 16934317

4

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

Walsh CS, Miller CW, Karlan BY, Koeffler HP. Walsh CS, et al. Gynecol Oncol. 2007 Mar;104(3):660-4. doi: 10.1016/j.ygyno.2006.10.008. Epub 2006 Nov 21. Gynecol Oncol. 2007. PMID: 17123590

5

Contemporary progress in ovarian cancer screening.

Walsh CS, Karlan BY. Walsh CS, et al. Curr Oncol Rep. 2007 Nov;9(6):485-93. doi: 10.1007/s11912-007-0068-2. Curr Oncol Rep. 2007. PMID: 17991357 Review.

6

ERCC5 is a novel biomarker of ovarian cancer prognosis.

Walsh CS, Ogawa S, Karahashi H, Scoles DR, Pavelka JC, Tran H, Miller CW, Kawamata N, Ginther C, Dering J, Sanada M, Nannya Y, Slamon DJ, Koeffler HP, Karlan BY. Walsh CS, et al. J Clin Oncol. 2008 Jun 20;26(18):2952-8. doi: 10.1200/JCO.2007.13.5806. J Clin Oncol. 2008. PMID: 18565881

7

Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.

Fejzo MS, Dering J, Ginther C, Anderson L, Ramos L, Walsh C, Karlan B, Slamon DJ. Fejzo MS, et al. Genes Chromosomes Cancer. 2008 Oct;47(10):873-83. doi: 10.1002/gcc.20592. Genes Chromosomes Cancer. 2008. PMID: 18615678

8

Lymphadenectomy's role in early endometrial cancer: prognostic or therapeutic?

Walsh CS, Karlan BY. Walsh CS, et al. J Natl Cancer Inst. 2008 Dec 3;100(23):1660-1. doi: 10.1093/jnci/djn413. Epub 2008 Nov 25. J Natl Cancer Inst. 2008. PMID: 19033560 No abstract available.

9

Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas.

Walsh CS, Ogawa S, Scoles DR, Miller CW, Kawamata N, Narod SA, Koeffler HP, Karlan BY. Walsh CS, et al. Clin Cancer Res. 2008 Dec 1;14(23):7645-51. doi: 10.1158/1078-0432.CCR-08-1291. Clin Cancer Res. 2008. PMID: 19047089 Free PMC article.

10

Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.

Ioffe YJ, Li AJ, Walsh CS, Karlan BY, Leuchter R, Forscher C, Cass I. Ioffe YJ, et al. Among authors: walsh cs. Gynecol Oncol. 2009 Dec;115(3):466-71. doi: 10.1016/j.ygyno.2009.08.014. Epub 2009 Sep 20. Gynecol Oncol. 2009. PMID: 19767065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page